NYSE:RFL Rafael (RFL) Stock Price, News & Analysis → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free RFL Stock Alerts $1.60 -0.04 (-2.44%) (As of 05/21/2024 ET) Add Compare Share Share Today's Range$1.59▼$1.6650-Day Range$1.55▼$1.8452-Week Range$1.44▼$2.52Volume11,036 shsAverage Volume23,434 shsMarket Capitalization$39.33 millionP/E Ratio16.00Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Rafael alerts: Email Address Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution About Rafael Stock (NYSE:RFL)Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.Read More RFL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RFL Stock News HeadlinesMay 21 at 6:24 PM | msn.comWatch: Rafael Nadal arrives in Paris. Is this his final Roland Garros?May 21 at 6:24 PM | msn.comRafael Marchan returns to IronPigs, who end 4-game losing streakMay 21 at 1:23 PM | nytimes.comRafael Devers trots into Red Sox history books; baseball’s most exciting playMay 21 at 1:23 PM | msn.comRed Sox’s Rafael Devers draws ‘freak’ reaction after breaking Boston home run recordMay 21 at 1:23 PM | msn.comWhere Rafael Devers's Red Sox Home Run Record Ranks in MLB HistoryMay 21 at 8:23 AM | msn.comSan Rafael encampment seeks restraining order against business over nighttime musicMay 21 at 1:41 AM | msn.comRafael Devers breaks Red Sox record with homer in 6th consecutive gameMay 21 at 1:41 AM | msn.comPowerfully unique ability makes Red Sox slugger Rafael Devers’s home run streak that much more impressiveMay 21 at 1:41 AM | msn.comRafael Devers sets Red Sox record, homers in 6th straight gameMay 21 at 1:41 AM | msn.comRafael Devers hits home run in record 6th straight game to lift Red Sox past RaysMay 21 at 1:41 AM | msn.comWhy Rafael Devers’ record-setting HR wasn’t his favorite part of Red Sox winMay 21 at 1:41 AM | msn.comRafael Devers sets team record by homering in 6th straight game as Red Sox top Rays 5-0May 20 at 8:40 PM | msn.comRafael Devers tries to make history as Red Sox return to their house of horrors (lineups)May 20 at 8:40 PM | msn.comRed Sox 3B Rafael Devers breaks a franchise recordMay 20 at 8:40 PM | forbes.comRafael Nadal Practices At French Open Amid Questions About FitnessMay 20 at 8:40 PM | msn.comRafael Devers makes Red Sox history, hitting homer for sixth straight gameMay 20 at 3:19 PM | msn.comRafael Nadal returns to Roland Garros to practice amid doubts over his fitness and formMay 20 at 3:19 PM | msn.comRafael Nadal Received Huge Ovation Upon Arriving at Likely Last French OpenMay 20 at 3:19 PM | msn.comRafael Nadal returns to Roland Garros to practice amid doubts over fitness and formMay 20 at 3:19 PM | msn.com‘It’s fun to watch’: Red Sox teammates impressed with Rafael Devers’s home run streakMay 19 at 11:50 PM | msn.comIs Rafael Nadal playing in the French Open 2024?May 19 at 8:48 AM | msn.comToni Nadal issues big claim on how Roger Federer impacted Rafael Nadal at WimbledonMay 19 at 8:48 AM | latimes.comRafael CohenMay 19 at 12:59 AM | msn.comWatch: Rafael Devers Tie Up Game 2 Against St. Louis With a Home RunMay 18 at 9:58 AM | msn.comRafael Nadal And Roger Federer's Rivarly Takes Center Court In Louis Vuitton AdSee More Headlines Receive RFL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rafael and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/13/2024Today5/21/2024Next Earnings (Estimated)6/11/2024Fiscal Year End7/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Real estate Sub-IndustryN/A Current SymbolNYSE:RFL CUSIPN/A CIK1713863 Webwww.rafaelholdings.com Phone(212) 658-1450FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.10 Trailing P/E Ratio15.92 Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,880,000.00 Net Margins776.36% Pretax Margin827.64% Return on Equity-4.31% Return on Assets-4.22% Debt Debt-to-Equity RatioN/A Current Ratio23.01 Quick Ratio23.01 Sales & Book Value Annual Sales$275,000.00 Price / Sales142.29 Cash FlowN/A Price / Cash FlowN/A Book Value$3.98 per share Price / Book0.40Miscellaneous Outstanding Shares24,584,000Free Float22,199,000Market Cap$39.13 million OptionableOptionable Beta1.27 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Howard S. Jonas (Age 68)Founder & Executive Chairman Comp: $40kMr. William Conkling (Age 52)CEO & President Comp: $751.95kMr. David A. Polinsky Esq. (Age 52)Chief Financial Officer Comp: $363.3kMs. Barbara A. Ryan (Age 64)Investor Relations Officer Mr. Gus KodershaChief Technical Operations OfficerDr. Rick EwingHead of Drug DiscoveryDr. John Mayer Goldberg M.D. (Age 51)Chief Medical Officer Ms. Joyce J. Mason Esq. (Age 65)Corporate Secretary More ExecutivesKey CompetitorsQuince TherapeuticsNASDAQ:QNCXCara TherapeuticsNASDAQ:CARANatural Alternatives InternationalNASDAQ:NAIIModular MedicalNASDAQ:MODDLexaria BioscienceNASDAQ:LEXXView All CompetitorsInstitutional OwnershipMarquette Asset Management LLCBought 49,256 shares on 5/7/2024Ownership: 0.200%View All Institutional Transactions RFL Stock Analysis - Frequently Asked Questions How have RFL shares performed in 2024? Rafael's stock was trading at $1.83 on January 1st, 2024. Since then, RFL stock has decreased by 12.9% and is now trading at $1.5931. View the best growth stocks for 2024 here. When is Rafael's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 11th 2024. View our RFL earnings forecast. How were Rafael's earnings last quarter? Rafael Holdings, Inc. (NYSE:RFL) announced its quarterly earnings data on Wednesday, March, 13th. The company reported ($0.08) earnings per share for the quarter. The company had revenue of $0.07 million for the quarter. Rafael had a negative trailing twelve-month return on equity of 4.31% and a net margin of 776.36%. Who are Rafael's major shareholders? Rafael's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Marquette Asset Management LLC (0.20%). View institutional ownership trends. How do I buy shares of Rafael? Shares of RFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:RFL) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiden Nomination CANCELED?The Freeport SocietyWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rafael Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.